These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17855689)

  • 1. Counterpoint: genetic risk feedback for common disease time to test the waters.
    Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1727-9. PubMed ID: 17855689
    [No Abstract]   [Full Text] [Related]  

  • 2. Point: genetic risk feedback for common disease time to test the waters.
    McBride CM; Brody LC
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1724-6. PubMed ID: 17855688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosing predisposition to tumor development by genetic typing].
    Thomas G
    Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B1-4. PubMed ID: 8761114
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic gene allele nomenclature.
    Garte S; Boffetta P; Caporaso N; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1305-6. PubMed ID: 11751451
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of pediatric cancer and complex diseases: aren't they all?
    Chanock S; Yeager M
    Pediatr Blood Cancer; 2007 Jun; 48(7):719-22. PubMed ID: 17226845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a knowledge base on genetic variation and cancer risk through field synopses.
    Yesupriya A; Gwinn M; Khoury MJ
    J Natl Cancer Inst; 2009 Jan; 101(1):4-5. PubMed ID: 19116390
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized cancer diagnostics and therapeutics.
    Roukos DH
    Expert Rev Mol Diagn; 2009 Apr; 9(3):227-9. PubMed ID: 19379081
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic variations as cancer prognostic markers: review and update.
    Savas S; Liu G
    Hum Mutat; 2009 Oct; 30(10):1369-77. PubMed ID: 19639655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.
    Romanos J; van Diemen CC; Nolte IM; Trynka G; Zhernakova A; Fu J; Bardella MT; Barisani D; McManus R; van Heel DA; Wijmenga C
    Gastroenterology; 2009 Sep; 137(3):834-40, 840.e1-3. PubMed ID: 19454285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults.
    Pezzini A; Grassi M; Del Zotto E; Lodigiani C; Ferrazzi P; Spalloni A; Patella R; Giossi A; Volonghi I; Iacoviello L; Magoni M; Rota LL; Rasura M; Padovani A
    Neurology; 2009 Sep; 73(9):717-23. PubMed ID: 19720979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in identifying genetic risk factors for common multifactorial disorders.
    Phadke SR
    Indian J Med Res; 2008 Feb; 127(2):106-9. PubMed ID: 18403786
    [No Abstract]   [Full Text] [Related]  

  • 12. Studying genetic variations in cancer prognosis (and risk): a primer for clinicians.
    Savas S; Liu G
    Oncologist; 2009 Jul; 14(7):657-66. PubMed ID: 19581524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
    Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenting quality interacts with genetic variation in dopamine receptor D4 to influence temperament in early childhood.
    Sheese BE; Voelker PM; Rothbart MK; Posner MI
    Dev Psychopathol; 2007; 19(4):1039-46. PubMed ID: 17931433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention.
    Roukos DH
    Expert Rev Mol Diagn; 2009 Jan; 9(1):1-6. PubMed ID: 19099341
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenes, risk prediction, and targeted prevention of breast cancer.
    Jernström H
    N Engl J Med; 2008 Sep; 359(13):1407. PubMed ID: 18822457
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five genetic variants associated with prostate cancer.
    Gartner CE; Barendregt JJ; Hall WD
    N Engl J Med; 2008 Jun; 358(25):2738-9; author reply 2741. PubMed ID: 18572445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.